Study | Year | Sample time (year.month) | Cases LA/ OA | Age (years) | Sex (male/female) | Study design | Outcome measures | ||
---|---|---|---|---|---|---|---|---|---|
LA group | OA group | LA group | OA group | ||||||
Xu Huadong | 2021 | 2019.05–2020.10 | 41/41 | 54.37 ± 2.56 | 53.25 ± 2.54 | 27/14 | 28/13 | RCT | ①②③④⑤⑥⑦⑧ |
Yuan Bo | 2019 | 2005.01–2015.12 | 422/109 | 40.5 ± 16.1 | 41.3 ± 15.5 | 272/150 | 70/39 | Retrospective | ①④⑤⑥⑦⑧ |
Yi Zhengguo | 2021 | 2016.01–2019.01 | 40/40 | 46.64 ± 5.47 | 46.52 ± 5.39 | 27/13 | 28/12 | RCT | ①③④⑤⑥⑦⑧ |
Yang Yuetao | 2014 | 2011.06–2013.06 | 36/36 | 50.6 ± 7.4 | 50.6 ± 7.4 | 22/14 | 23/13 | RCT | ①⑤⑥⑦⑧ |
Gong Wei | 2018 | 2011.01–2015.12 | 57/45 | 9.39 ± 2.90 | 9.24 ± 2.43 | 33/24 | 26/19 | Retrospective | ①⑤⑥⑦⑧ |
Shen Zhenghai | 2016 | 2010.09–2015.09 | 115/138 | 39.9 ± 14.96 | 38.03 ± 15.62 | 70/45 | 79/59 | Retrospective | ①②⑤⑦⑧ |
Li Yongchao | 2014 | 2010.01–2011.02 | 35/42 | 41.3 ± 17.3 | 44.8 ± 16.5 | 17/18 | 20/22 | Retrospective | ①②⑤⑦⑧ |
Liu Wenbin | 2020 | 2017.01–2019.12 | 28/28 | 36.64 ± 3.71 | 36.58 ± 3.65 | 16/12 | 15/13 | RCT | ①④⑤⑥⑦⑧ |
Le Hao | 2020 | 2016.09–2018.12 | 43/43 | 43.15 ± 4.78 | 43.10 ± 4.83 | 21/22 | 20/23 | RCT | ①②③④⑤⑥⑦⑧ |
Wu Ji | 2014 | 2010.03–2013.12 | 62/54 | 36.5 ± 5.82 | 36.8 ± 6.26 | 31/31 | 27/27 | RCT | ①⑥⑦⑧ |
TomoyaTakami | 2020 | 2011.01–2017.12 | 90/89 | 50.13 ± 25.84 | 50.17 ± 22.77 | 62/28 | 56/33 | Retrospective | ①③④⑤⑥⑦⑧ |
VincenzoMinutolo | 2014 | 2008.05–2012.05 | 139/91 | 12–73 | 12–48 | 62/77 | 43/48 | Retrospective | ①②⑤⑦⑧ |
SaeedKargar | 2011 | 2008.04–2009.04 | 50/50 | 26.94 ± 9.51 | 25.36 ± 8.92 | 23/27 | 28/22 | RCT | ①⑤ |
Ching-ChungTsai | 2012 | 2000.01–2004.11 | 20/32 | 9.6 ± 3.6 | 9.4 ± 3.3 | 12/8 | 21/11 | Retrospective | ①②③④⑤⑧ |
AliKocataş | 2013 | NP | 50/46 | 27.4 ± 18.5 | 28.2 ± 21.2 | 27/23 | 42/4 | RCT | ① |
TatyanCLArke | 2011 | 1997.01–2001.12 | 23/14 | 19–60 | 18–50 | 15/8 | 9/5 | RCT |